Tata Consumer Products Gains 4% After Q2 Results; Margin Recovery Eyed

Tata Consumer’s Results Put Pricing Power and Margins in Focus

Sales growth held firm in the September quarter, but investors are looking for price increases to translate into a steadier margin recovery.

Growth businesses and salt support quarterly sales

Tata Consumer Products posted consolidated profit of ₹470 crore on revenue of ₹5,661 crore in the September quarter. Growth in revenue was supported by continued momentum in Sampann and NourishCo, as well as better-than-expected growth in the salt business. The results were described as broadly in line with expectations.

That mix matters because the quarter’s story was not just about headline sales growth: the company also needs to convert growth into improved profitability. EBITDA margin was 13.8%, up from 13.5% a year earlier. Analysts said weakness in India margins was offset by stronger margins in international and non-branded operations, leaving overall margin performance in line with expectations.

Price increases set the test for margin recovery

The company has taken calibrated tea price increases of 8–10% since the first quarter of FY27 to respond to cost inflation. It also raised salt prices by 13% to pass on higher costs. Those moves may support profitability, but their effect depends on how they flow through sales and margins in subsequent quarters.

JM Financial expects the full benefits of the tea and salt price increases to become visible in the third quarter, alongside stable profitability in the international and non-branded businesses. Elara Capital pointed to improving international margins and stronger growth in Capital Foods as potential contributors to expansion. Management is focused on margin improvement in FY27; the cited analyst estimate is for a 40-basis-point rise. These are expectations, not guaranteed outcomes.

Brokerages see growth potential, but have cut targets

The share price rose as much as 4.2% intraday, from a previous close of ₹936.60 to a high of ₹976.30, after the results were released. The move followed a reported 18% correction over the preceding three months, but one session’s reaction does not resolve the central question for investors: whether margins can recover while the business sustains growth.

JM Financial maintained an ADD rating but cut its target price to ₹1,065 from ₹1,225, citing a lower valuation multiple amid sector derating and volatility in margin delivery. Elara Capital retained ACCUMULATE and reduced its target to ₹1,080 from ₹1,290, while raising its earnings estimates for FY27, FY28 and FY29. The lower targets alongside constructive ratings show that analysts see potential, but are also accounting for execution and valuation concerns.

SBI Securities also described the near-term growth outlook as constructive, highlighting growth categories, distribution expansion and innovation. It identified tea demand recovery and input costs as important monitorables. For investors, the next evidence will be whether price actions protect margins without weakening demand, particularly in the India business.

Key Highlights

• Consolidated profit rose 15.7% year on year to ₹470 crore; revenue increased 14% to ₹5,661 crore.
• EBITDA margin improved to 13.8% from 13.5% a year earlier.
• Tea prices were raised 8–10% and salt prices 13% to address cost inflation.
• Analysts expect price actions and international business profitability to support margin recovery, but execution remains a risk.
• Brokerages retained positive ratings while lowering target prices amid margin uncertainty and sector derating.

Investor Note: The quarter shows resilient sales growth, but the investment case also depends on the pace of India margin recovery, demand response to price increases and the company’s ability to sustain growth in its faster-growing businesses. Investors may want to assess those developments over subsequent quarters rather than rely on a single-day share-price move.